肾皮质氧合降低可预测慢性肾脏病患者肾功能进行性下降
该前瞻性研究纳入112例CKD患者、47例无CKD高血压患者和24例健康对照,用BOLD-MRI测量肾组织氧合,随访三年。校正年龄、性别、糖尿病、RAS阻断剂、eGFR和蛋白尿后,eGFR年变化与基线24小时蛋白尿及皮质层平均R2*值负相关,与R2*斜率正相关;高外层R2*或平坦R2*斜率的CKD患者发生不良肾脏结局的风险高3倍。
要点
- 低皮质氧合是CKD肾功能下降的独立预测因子。
- 高外层R2*或平坦R2*斜率者不良肾脏结局风险高3倍。
- BOLD-MRI测得的皮质氧合可辅助CKD风险分层。
核心结论
- 低皮质氧合是肾功能下降的独立预测因子。
研究设计与样本
- 前瞻性研究,纳入112例CKD患者、47例无CKD高血压患者和24例健康对照,随访三年。
- 用BOLD-MRI测量肾组织氧合,以十二层同心物体法分析,报告各层平均R2*值及层间R2*变化(R2*斜率)。
- 收集血肌酐计算MDRD eGFR年变化。
主要发现
- CKD、高血压和对照组的eGFR年变化分别为-2.0、0.5和-0.2 ml/min/1.73m2/year。
- 多变量回归校正年龄、性别、糖尿病、RAS阻断剂、eGFR和蛋白尿后,eGFR年变化与基线24小时蛋白尿及皮质层平均R2*值负相关,与R2*斜率正相关。
- 高外层R2*或平坦R2*斜率的CKD患者发生不良肾脏结局(肾脏替代治疗或血肌酐增加超过30%)的风险高3倍。
关键数值与推荐
- 高R2*对应低氧合;R2*斜率指层间R2*变化。
- 不良肾脏结局定义为肾脏替代治疗或血肌酐增加超过30%。
临床怎么用
- BOLD-MRI测得的皮质氧合可用于CKD患者肾功能下降的风险评估。
- 高外层R2*或平坦R2*斜率的CKD患者需加强监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Renal tissue hypoxia is a final pathway in the development and progression of chronic kidney disease (CKD), but whether renal oxygenation predicts renal function decline in humans has not been proven. Therefore, we performed a prospective study and measured renal tissue oxygenation by blood oxygenation level-dependent magnetic resonance imaging (BOLD-MRI) in 112 patients with CKD, 47 with hypertension without CKD, and 24 healthy control individuals. Images were analyzed with the twelve-layer concentric objects method that divided the renal parenchyma in 12 layers of equal thickness and reports the mean R2* value of each layer (a high R2* corresponds to low oxygenation), along with the change in R2* between layers called the R2* slope. Serum creatinine values were collected to calculate the yearly change in estimated glomerular function rate (MDRD eGFR). Follow up was three years. The change in eGFR in CKD, hypertensive and control individuals was -2.0, 0.5 and -0.2 ml/min/1.73m2/year, respectively. In multivariable regression analysis adjusted for age, sex, diabetes, RAS-blockers, eGFR, and proteinuria the yearly eGFR change correlated negatively with baseline 24 hour proteinuria and the mean R2* value of the cortical layers, and positively with the R2* slope, but not with the other covariates. Patients with CKD and high outer R2* or a flat R2* slope were three times more likely to develop an adverse renal outcome (renal replacement therapy or over a 30% increase in serum creatinine). Thus, low cortical oxygenation is an independent predictor of renal function decline. This finding should stimulate studies exploring the therapeutic impact of improving renal oxygenation on renal disease progression.
引用
- Pruijm M, Milani B, Pivin E, et al. Reduced cortical oxygenation predicts a progressive decline of renal function in patients with chronic kidney disease. Kidney Int. 2018. PMID: 29325997. doi:10.1016/j.kint.2017.10.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。